A Peak at HPLC

In 1906, Mikhail Tswett separated plant pigments on a chalk column. Alluding to the separated colors, he termed his technique chromatography.1 Nearly a century later, chromatography hasn't changed all that much; it still relies on the differential affinities of analyte components for the mobile and stationary phases of the separation. Yet in high-performance liquid chromatography (HPLC), the technique assumes a decidedly high-tech air, with gleaming stainless steel components, computer control

Written byJeremy Peirce
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

In 1906, Mikhail Tswett separated plant pigments on a chalk column. Alluding to the separated colors, he termed his technique chromatography.1 Nearly a century later, chromatography hasn't changed all that much; it still relies on the differential affinities of analyte components for the mobile and stationary phases of the separation. Yet in high-performance liquid chromatography (HPLC), the technique assumes a decidedly high-tech air, with gleaming stainless steel components, computer control, and advanced detectors.

The stationary phase is typically packed into a small column through which the mobile phase migrates. An injector valve introduces the analyte into the mobile phase, and one or more detectors scan the column output. This general setup describes most medium-pressure and low-pressure systems, as well. Lou Bellafiore, president of TechniKrom in Evanston, Ill., points out that the basic distinction "is really the backpressure generated by the [stationary phase] particle size .... Ultimately the particle size dictates ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies